Bayforest Capital’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51K Sell
1,441
-6,746
-82% -$209K 0.06% 551
2025
Q4
$229K Buy
+8,187
New +$245K 0.17% 242
2025
Q3
Sell
-11,242
Closed -$322K 726
2025
Q2
$322K Buy
11,242
+1,972
+21% +$58.7K 0.14% 287
2025
Q1
$306K Buy
9,270
+4,752
+105% +$155K 0.13% 290
2024
Q4
$130K Buy
+4,518
New +$130K 0.16% 242

Other funds holding ALKS

Bayforest Capital's ALKS Position: Q1 2026 in Review

Bayforest Capital reduced its Alkermes (ALKS) stake by 82% in Q1 2026, selling an estimated $209K and leaving 1,441 shares worth $51K. The position accounts for 0.06% of the portfolio, ranked #551.

Bayforest Capital first reported a position in ALKS in Q4 2024 and has held it in 5 quarters since. The position peaked at $322K in Q2 2025. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Bayforest Capital held 1,441 shares of Alkermes worth $51K as of Q1 2026.
  • Bayforest Capital sold 6,746 Alkermes shares in Q1 2026, an estimated $209K.
  • Alkermes made up 0.06% of Bayforest Capital's portfolio in Q1 2026, its #551 holding.
  • Bayforest Capital first reported a position in Alkermes in Q4 2024 and has held it in 5 quarters since.
  • Bayforest Capital's Alkermes position peaked at $322K in Q2 2025.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.